IL6 and head and neck squamous cell carcinoma: Furthermore, clinical studies have reported increased IL-6 serum levels and salivary IL-6 concentration in OSCC patients compared to patients with leukoplakia and healthy controls, suggesting that IL-6 could be a crucial biomarker in HNSCC diagnosis [27, 28].